Clinical trial

Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males

NCT00719394

Study summary

ClinicalTrials.gov

Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention GSI 136 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE1

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Healthyunresolved

Interventions

GSI 136DRUG

placeboDRUG

Sponsors & collaborators

Wyeth is now a wholly owned subsidiary of Pfizerlead sponsor

Mapped research locations

TokyoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00719394 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.